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Abstract
Background: So far, few data have been available on the incidence and outcome of patients with 
acute myocardial infarction (MI) requiring mechanical ventilation (MV). The aim of the study was  
to assess the clinical and prognostic impact of MV at short and long term in 106 patients with  
ST elevation MI (STEMI) requiring mechanical ventilation.
Results: The incidence of mechanical ventilation was 7.6%. Reasons for intubation were 
as follows: cardiogenic shock in 64 (60.4%) patients, ventricular fibrillation in 32 (30.1%) 
patients and acute pulmonary edema in 10 (9.5%) patients. Patients submitted to MV were 
older (p = 0.016), more frequently had a previous percutaneous coronary intervention (PCI;  
p = 0.014) and a previous MI (p = 0.001). A higher in-Intensive Cardiac Care Unit death 
was observed in MV patients (44.3% vs. 1.5%, p < 0.001), as well as a higher mortality at 
follow-up (36.7% vs. 14.8%, p < 0.001). MV was associated with higher mortality rates both 
at short and long term.
Conclusions: In a large series of consecutive STEMI patients submitted to MV, the need of 
MV is a strong prognostic indicator of mortality both at short and long term. Among mechani-
cally ventilated STEMI patients infarct size (as inferred by TnI values) and PCI failure were 
independent predictors of early death, while the duration of MV was related to death at long 
term. (Cardiol J 2013; 20, 6: 612–617)
Key words: ST elevation myocardial infarction, mechanical ventilation,  
percutaneous coronary intervention, prognosis, long term
Introduction
In critically ill patients, mechanical ventila-
tion (MV), and its impact on outcome has been 
extensively studied [1–3], while so far few data 
have been available on the incidence and outcome 
of patients with acute myocardial infarction (MI) 
requiring MV [4–7].
The present investigation was aimed at as-
sessing the clinical characteristics and prognosis 
(both at short and long term) of 106 consecutive 
patients with ST elevation MI (STEMI) requiring 
MV, all treated with primary percutaneous coronary 
intervention (PCI) and admitted to our Intensive 
Cardiac Care Unit (ICCU).
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Methods
From 1 April 2004 to 31 December 2010, 1231 
consecutive patients with STEMI (within 12 h from 
symptoms’ onset) [8] were admitted to our ICCU, 
which is located at a tertiary center. In our hospital, 
in Florence, the reperfusion strategy of STEMI 
patients is represented by primary PCI [9–12] (no 
exclusion criteria). STEMI patients are first eva-
luated by the Medical Emergency System staff in 
the pre-hospital setting and then directly admitted 
to the catheterization laboratory or transferred to 
it after a rapid stabilization in the First Aid. After 
primary PCI, they are admitted to our ICCU. Data 
were stored in a prospective registry on which 
a retrospective analysis had been carried out.
A successful procedure was defined as an 
infarct artery stenosis < 20% associated with 
Thrombolysis In Myocardial Infarction (TIMI) 
grade 3 flow. Failure PCI was defined as resulting 
in TIMI grade 0 to 2 flow, regardless the residual 
stenosis.
The diagnosis of STEMI was based on the 
criteria of the American College of Cardiology/ 
/American Heart Association [13].
On ICCU admission, after PCI, in a fasting 
blood sample the following parameters were me-
asured: sodium [mEq/L], glucose [g/L], glycated 
hemoglobin [Hb, %], troponin I [TnI, ng/mL], uric 
acid [mg/dL], NT-pro B-type natriuretic peptide 
[NT-proBNP, pg/mL], erythrocyte sedimentation 
rate (ESR), leukocytes count [×103/µL], fibrinogen 
[mg/dL] and hs-C-reactive protein positivity (hs-
-CRP). Creatinine [mg/dL] was also measured, in 
order to calculate glomerular filtration rate [GFR, 
mL/min/1.73 m2], on admission and at discharge 
[14]. Glucose, TnI and creatinine were measured 
3 times a day and peak values were examined. 
Acute insulin resistance was assessed by means 
of the Homeostatic Model Assessment (HOMA), 
as previously described [15].
Transthoracic 2-dimensional echocardiograp-
hy was performed on ICCU admission in order to 
measure left ventricular ejection fraction (LVEF).
Ventilatory support (invasive and non-invasive 
ventilation), ultrafiltration (continuous-veno-ve-
nous ultrafiltration, CVVHDF) and intra-aortic 
balloon pump (IABP) implantation were used when 
needed [9, 11].
According to the policy of our center, sedoan-
algesia (propofol + remifentanil) was administered 
to patients submitted to MV.
The primary endpoint was in-ICCU death and 
all-cause mortality at follow-up.
The study protocol was in accordance with the 
Declaration of Helsinki and approved by the local 
Ethics Committee. Informed consent was obtained 
from all the patients before enrollment.
Statistical analysis
Statistical analysis has been conducted with 
PASW 17.0 for Windows software (SPSS Inc, 
Chicago, IL). In all cases, a 2-tailed p < 0.05 has 
been considered statistically significant. After 
assessment of normality by means of Kolmogorov-
-Smirnov test for one sample, continuous variables 
have been reported as mean ± standard deviation 
or median (interquartile range: IQR); categorical 
variables have been depicted as frequency (percen-
tage). For continuous variables, between-groups 
comparisons have been performed with Student’s 
t-test or by means of Mann-Whitney U test. Cate-
gorical variables have been compared with c2 or 
Fisher’s exact test when needed.
In the overall population predictors of death, 
both in-ICCU and at follow-up, have been inve-
stigated by means of logistic and Cox regression 
analyses, respectively. In multivariable analyses 
candidate variables were carefully chosen among 
those known to be clinically related to outco-
me in order to avoid model overfitting. Possible 
predictors for in-ICCU death were age (1 year 
step), admission glycemia (1 g/L step), LVEF 
(1% step), admission estimated GFR (eGFR; 
1 mL/min/1.73 m2 step), admission Hb (1 g/dL 
step) and MV; for long-term death candidate pre-
dictors were age (1 year step), nadir eGFR (1 mL/ 
/min/1.73 m2 step), admission Hb (1 g/dL step), 
LVEF (1% step), previous acute MI and MV.
To adjust to the need of MV, a propensity analy-
sis was carried out using a non-parsimonious logistic 
regression to determine the probability of a patient 
to receive MV. The variables included in the pro-
pensity score model were age, gender, previous PCI, 
previous MI, symptom-to-balloon time, PCI failure, 
length of ICCU stay, admission glycemia, peak TnI, 
history of hypertension, history of diabetes, smoking 
habit, location of the STEMI, heart rate and blood 
pressure at admission, and Killip’s classification at 
admission. The goodness-of-fit of the propensity 
score model was obtained by the c-statistics.
Results
In our series, the incidence of MV was 7.6% 
(106/1294). In the pre-hospital setting 55 patients 
were intubated (51.8%), 18 patients in the Ca-
theterization Laboratory (16.9%), 24 patients on 
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hospital admission in the Emergency Department 
(22.6%) and the remaining 9 (8.7%) patients in ICCU. 
Reasons for intubation were as follows: cardiogenic 
shock in 64 (60.4%) patients, ventricular fibrillation 
in 32 (30.1%) patients and acute pulmonary edema in 
10 (9.5%) patients. Non invasive ventilation was per-
formed in 6 patients (all with acute pulmonary edema) 
but it was unsuccessful and they were promptly intu-
bated. Tracheotomy was performed in 11 (10.3%) 
patients, in all but one percutaneously. One patient 
accidentally auto-extubated and was promptly re-
-intubated. Among patients discharged alive, MV 
was stopped in 37 patients (37/59, 62.7%) within 
the first 48 h since ICCU admission. Ventilatory 
associated pneumonia was observed in 23 (21.6%) 
patients, among whom 15 patients died.
As depicted in Table 1, patients submitted to MV 
were older (p = 0.016), more frequently had a pre-
vious PCI (p = 0.014) and a previous MI (p = 0.001). 
Time to symptoms-to-balloon was longer in MV 
patients (p = 0.010) who showed more frequently 
an anterior wall MI (p = 0.005), a higher inciden-
ce of PCI failure (p < 0.001), advance Killip class 
(p < 0.001) and a longer length of stay (p < 0.001). 
A higher in-ICCU death was observed in MV pa-
tients (p < 0.001), as well as a higher mortality at 
follow-up.
As depicted in Table 2, MV patients showed 
higher values of admission and peak glycemia 
(p < 0.001 and p < 0.001, respectively), peak TnI 
(p < 0.001), NT-proBNP (p < 0.001), uric acid 
(p < 0.001) and a higher incidence of HOMA 
Table 1. Clinical characteristics.
No MV
N = 1188 (91.8%)
MV
N = 106 (7.6%) 
P






Body mass index [kg/m2] 26.3 ± 3.6 25.8 ± 3.8 0.145
History of:
Diabetes mellitus 310 (24.0%) 33 (31.1%) 0.099
Smoking 812 (62.8%) 55 (51.9%) 0.027
COPD 117 (9.0%) 7 (6.6%) 0.396
Previous PCI 170 (13.1%) 23 (21.7%) 0.014
Previous MI 169 (13.1%) 26 (24.5%) 0.001
Hypertension 684 (52.9%) 56 (52.8%) 0.995
Symptoms-to-balloon time [min], median (IQR) 226 (150–300) 279 (180–335) 0.010
Acute MI location: 0.005
Anterior 665 (51.4%) 74 (69.8%)
Inferior 525 (40.6%) 24 (22.6%)
Other 104 (8.0%) 8 (7.5%)
Coronary artery disease: 0.060
1-vessel 517 (40.0%) 30 (28.3%)
2-vessel 430 (33.2%) 43 (40.6%)
3 - vessel 347 (26.8%) 33 (31.1%)
Left main coronary artery 71 (5.5%) 14 (13.2%) 0.001
CABG 31 (2.4%) 1 (0.9%) 0.508
PCI failure 66/1282 (5.1%) 20/105 (19.0%) < 0.001
Killip class: < 0.001
I–II 1080 (92.4%) 42 (39.6%)
III–IV 89 (7.6%) 64 (60.4%)
Admission LVEF [%] 42 (35–50%) 40 (35–48%) 0.025
LOS [h], median (IQR) 66 (48–90) 96 (50–168) < 0.001
ICCU-death 19 (1.5%) 47 (44.3%) < 0.001
Follow-up death (n = 1081) 153/1032 (14.8%) 18/49 (36.7%) < 0.001
MV — mechanical ventilation; COPD — chronic obstructive pulmonary disease; PCI — percutaneous coronary intervention; MI — myocardial 
infarction; IQR — interquartile range; CABG — coronary artery bypass graft; LVEF — left ventricular ejection fraction; LOS — length of stay; 
ICCU — intensive cardiac care unit
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positivity (p < 0.001). Lower values on admission 
and nadir eGFR (p < 0.001 and p < 0.001, respec-
tively) were observed in MV patients who exhibi-
ted a higher inflammatory activation, as inferred 
by higher values of ESR (p = 0.02), leukocytes 
(p < 0.01) and hs-CRP positivity (p < 0.001).
As shown in Table 3, MV patients were more 
frequently submitted to CVVHDF (p < 0.001) 
and IABP (p < 0.001), as well as to 2 or 3 devices 
simultaneously (p < 0.001).
At multivariable regression analysis, the 
following variables were independent predictors 
of in-ICCU death (when adjusted for admission 
eGFR): age (1 year step) (OR: 1.06, 95% CI 
1.03–1.10, p < 0.001); admission glycemia 
(1 g/L step) (OR: 1.65, 95% CI 1.09–2.50, 
p = 0.018); LVEF (1% step) (OR: 0.96, 95% CI 
0.93–1.00, p = 0.037); MV (OR: 6.72, 95% CI 
2.93–15.38, p < 0.001). Hosmer-Lemeshow go-
odness-of-fit test c2 11.3, p = 0.183; Nagelkerke 
pseudo R2 0.44.
Patients were followed-up for 37.9 (25th–75th 
percentile: 14.5–60.7) months.
At multivariable Cox regression analysis, the 
following variables were independent predictors 
of death at follow-up: age (1 year step) (HR: 1.06, 
95% CI 1.05–1.08, p < 0.001); nadir eGFR (1 mL/ 
/min/1.73 m2 step) (HR: 0.98, 95% CI 0.97–1.00, 
p < 0.001); LVEF (1% step) (HR: 0.98, 95% CI 
0.97–1.00, p = 0.010); MV (OR: 1.81, 95% CI 
1.08–3.05, p = 0.026).
Propensity score analysis
Area under the receiving operator characte-
ristic (ROC) curve was 0.95 (95% CI 0.91–0.98), 
p < 0.001.
Table 2. Laboratory data.
No MV
N = 1188 (91.8%)
MV
N = 106 (7.6%)
P
Admission glucose [mg/dL] 1.30 (1.09–1.60) 1.82 (1.35–2.71) < 0.001
Peak glycemia [mg/dL] 1.48 (1.25–1.87) 2.06 (1.71–3.05) < 0.001
Insulin [mU/L] 9.5 (5.6–16.8) 13.8 (5.2–41.8) 0.010
HOMA positivity [%] 106/757 (14.0) 25/58 (53.1) < 0.001
Glycated hemoglobin [%] 5.9 (5.6–6.4) 6.0 (5.7–6.6) 0.448
Admission eGFR [mL/min/1.73 m2] 85.7 ± 30.9 66.1 ± 38.8 < 0.001
Nadir eGFR [mL/min/1.73 m2] 72.9 ± 25.6 45.2 ± 28.3 < 0.001
Microalbuminuria [mg/dL] 16.7 (6.3–53.9) 41.6 (10.6–158.0) 0.001
Peak TnI [ng/mL] 80.4 (35.5–171.5) 128.9 (59.1–384.9) < 0.001
NT-proBNP [pg/mL] 1221 (426–3002) 3688 (1682–14356) < 0.001
Uric acid [mg/dL] 5.6 ± 1.7 7.0 ± 2.5 < 0.001
ESR [mm/h] 22 (12–40) 33 (17–55) 0.002
Leucocytes [×103/µL] 10.7 (8.7–13.4) 13.4 (11.1–18.7) < 0.001
hs-CRP positivity [%] 422/868 (48.6) 47/64 (73.4) < 0.001
Fibrinogen [mg/dL] 402 (339–478) 420 (342–526) 0.066
MV — mechanical ventilation; HOMA — homeostatic model assessment; eGFR — estimated glomerular filtration rate; TnI — troponin I; 
NT-proBNP — NT-pro B-type natriuretic peptide; ESR — erythrocyte sedimentation rate; CRP — C-reactive protein
Table 3. Devices.
Variable All patients No MV MV P
CVVHDF 54 (4.1%) 25 (2.1%) 29 (27.4%) < 0.001
IABP 298 (23.1%) 227 (19.1%) 71 (67.0%) < 0.001
2 device 73 (5.6%) 21 (1.7%) 
IABP, CVVHDF or cPAP
52 (49.1%) 
MV and (IABP or CVVHDF)
< 0.001
3 device 31 (2.3%) 7 (0.6%) 
IABP, CVVHDF or cPAP
24 (22.6%) 
MV and (IABP + CVVHDF)
< 0.001
MV — mechanical ventilation; CVVHDF — continuous-venous-venous ultrafiltration; IABP — intra-aortic balloon pump; cPAP — continuous 
positive airway pressure ventilation
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According to the propensity score analysis 
the incidence of in-ICCU mortality was higher in 
patients submitted to mechanical ventilation in 
respect to those who were not (44.3% vs. 12.3%, 
p < 0.001). At long term, the incidence of death 
was higher in patients who were submitted to MV, 
though it did not reach statistical significance (36.7 
vs. 27.8, p = 0.292).
At multivariable regression analysis MV was 
an independent predictor of early death (OR: 6.72, 
95% CI 2.93–15.38, p < 0.001).
At Cox regression analysis the following va-
riables were independent predictors of long term 
mortality (when adjusted for nadir eGFR): age 
(1 year step) (HR: 1.08, 95% CI 1.05–1.13, p < 0.001); 
MV (HR: 1.93, 95% CI 1.02–3.65, p = 0.044).
Among STEMI patients submitted  
to mechanical ventilation
At multivariable regression analysis, the fol-
lowing variables were independent predictors of 
in-ICCU death (when adjusted for age): TnI (10 g/ 
/mL) (OR: 1.03, 95% CI 1.01–1.06, p = 0.003); PCI 
failure (OR: 5.97, 95% CI 1.76–20.23, p = 0.004).
At multivariable Cox regression analysis, the 
following variables were independent predictors 
of death at follow-up (when adjusted for dischar-
ge LVEF): age (1 year step) (HR: 1.07, 95% CI 
1.02–1.12, p = 0.005); duration of MV (1 h/step) 
(HR: 1.01, 95% CI 1.00–1.02, p = 0.001).
Discussion
The main findings of the present investigation, 
performed in 106 consecutive STEMI patients 
requiring MV submitted to PCI, are as follows: 
a) MV in the early phase of STEMI is not uncom-
mon, being detectable in the 7.6% of the entire 
population; b) MV patients are older and show 
a larger infarct size (as indicated by higher values of 
peak TnI and NT-proBNP), a higher inflammatory 
activation (as inferred by higher values of hs-CRP 
positivity and leukocyte count); c) MV in the early 
phase of STEMI is associated with an increased 
risk of death both at short and long term.
So far, few data have been available on the 
prognostic impact of MV in acute MI and results 
are scarcely comparable due to differences in 
patients’ selection criteria (NSTEMI vs. STEMI) 
[4, 6, 16] and type of revascularization (thrombolysis 
vs. mechanical revascularization) [4, 7].
We reported, for the first time, the prognostic 
impact of MV in a large series of consecutive STEMI 
patients submitted to PCI. In our series the inci-
dence of MV was higher in respect to that reported 
previously (7.6% vs. 1.6%) [6], but differently from 
Eran et al. [6] we only included STEMI patients 
(instead of acute coronary syndrome patients).
In accordance with previous studies [4–6, 17] 
we observed that MV patients exhibited a higher 
mortality rate (44.3%). In 2001 Lopez Messa et 
al. [17] reported a 65.7% mortality rate among 
333 mechanically ventilated patients with acute 
MI in a retrospective analysis from the Spanish 
registry ARIAM (Analisis Retraso Infarto Agudo 
Miocardio). In 157 consecutive patients with acute 
MI requiring MV admitted to an intensive care 
unit and submitted to coronary reperfusion within 
12 h of symptom onset in-hospital mortality rate 
was 50.9%. Similarly, in a subgroup of consecutive 
STEMI and NSTEMI patients of the German BEAT 
registry the overall hospital mortality rate was 48% 
[4] and in a small series of 51 consecutive acute MI 
patients who received MV for > 24 h, mortality rate 
was 43%. In a recent paper by Bhave et al. [5], MV 
was one of the predictors of the development of left 
ventricular dysfunction in the course of STEMI.
In our series MV is a strong independent pre-
dictor for mortality, since MV patients are older, 
with a larger infarct size (as indicated by peak TnI) 
[18–20], hemodynamic impairment (as inferred 
by advanced Killip class) and a higher incidence 
of multi-organ dysfunction (as indicated by lower 
eGFR and a higher use of devices, often simulta-
neously implanted).
Moreover, in our population, MV was associa-
ted with higher mortality rates even at follow-up. 
This is in accordance with previous findings by 
Zahger et al. [16] who described in 2005 a 30-day 
mortality of 29% and a 1-year mortality of 46% in 
a retrospective cohort of 267 consecutive patients 
admitted to the coronary care unit for an acute 
coronary syndrome requiring MV.
According to our data, among STEMI patients 
submitted to MV, infarct size (as inferred by TnI 
values) and PCI failure are independent predictors 
of early death, thus underscoring, even in this sub-
group of STEMI patients, the impact on prognosis 
of a successful mechanical revascularization.
We observed, for the first time, that the du-
ration of MV is related to death at long term in 
STEMI patients mechanically ventilated; this fin-
ding strongly suggests that MV should be withheld 
as soon as possible in these patients. However, 
further studies performed in larger cohorts are 
needed to confirm these data.
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Conclusions
According to our data, among STEMI patients 
submitted to MV, infarct size (as inferred by TnI 
values) and PCI failure are independent predictors 
of early death, thus underscoring, even in this sub-
group of STEMI patients, the impact on prognosis 
of a successful mechanical revascularization. 
We observed, for the first time, that the du-
ration of MV is related to death at long term in 
STEMI patients mechanically ventilated; this finding 
strongly suggest that MV should be withheld as 
soon as possible in these patients. However further 
studies performed in larger cohorts are needed to 
confirm these data.
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